期刊
JOURNAL OF IMMUNOLOGY
卷 175, 期 9, 页码 6205-6210出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.175.9.6205
关键词
-
类别
资金
- NIAID NIH HHS [R15 AI089518-01, R15 AI089518] Funding Source: Medline
The resistance of inositol 1,4,5-trisphosphate receptor (IP3R)-deficient cells to multiple forms of apoptosis demonstrates the importance of IP3-gated calcium (Ca2+) release to cellular apoptosis. However, the specific upstream biochemical events leading to IP3-gated Ca2+ release during apoptosis induction are not known. We have shown previously that the cyclin-dependent kinase 1/cyclin B (cdk1/CyB or cdc2/CyB) complex phosphorylates IP(3)R1 in vitro and in vivo at Ser(421) and Thr(799). In this study, we show that: 1) the cdc2/CyB complex directly interacts with IP(3)R1 through Arg(391), Arg(441), and Arg(871); 2) IP(3)R1 phosphorylation at Thr(799) by the cdc2/CyB complex increases IP3 binding; and 3) cdc2/CyB phosphorylation increases IP3-gated Ca2+ release. Taken together, these results demonstrate that cdc2/CyB phosphorylation positively regulates IP3-gated Ca2+ signaling. In addition, identification of a CyB docking site(s) on IP(3)R1 demonstrates, for the first time, a direct interaction between a cell cycle component and an intracellular calcium release channel. Blocking this phosphorylation event with a specific peptide inhibitor(s) may constitute anew therapy for the treatment of several human immune disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据